Literature DB >> 33482771

Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population.

S Wiegand1, V Zebralla2, C Hammermüller1, A Hinz3, A Dietz1, G Wichmann1, M Pirlich1, T Berger1, K Zimmermann1, T Neumuth4, A Mehnert-Theuerkauf3.   

Abstract

BACKGROUND: Treatment of head and neck cancer (HNC) often leads to visible and severe functional impairments. In addition, patients often suffer from a variety of psychosocial problems, significantly associated with a decreased quality of life. We aimed to compare depression, anxiety, fatigue and quality of life (QoL) between HNC patients and a large sample of the general population in Germany and to examine the impact of sociodemographic, behavioral and clinical factors on these symptoms.
METHODS: We assessed data of HNC patients during the aftercare consultation at the Leipzig University Medical Center with a patient reported outcome (PRO) tool named "OncoFunction". Depression, anxiety, fatigue and QoL were assessed using validated outcome measures including the PHQ-9, the GAD-2, and the EORTC QLQ-C30 questionnaire.
RESULTS: A total of 817 HNC patients were included in our study and compared to a sample of 5018 individuals of the general German population. HNC patients showed significantly higher levels of impairment in all dimensions assessed. Examination of association between depression, anxiety, fatigue and QoL and clinical as well as sociodemographic variables showed significant relationships between occupational status, ECOG-state, body mass index and time since diagnosis.
CONCLUSIONS: HNC patients suffer significantly from psychological distress. The used questionnaires are suitable for the use in daily routine practice and can be helpful to increase the detection of depression, anxiety and fatigue and therefore can improve HNC aftercare.

Entities:  

Keywords:  Aftercare; Depression; Fatigue; Head neck cancer (HNC); Quality of life (QOL); Survivorship

Mesh:

Year:  2021        PMID: 33482771      PMCID: PMC7825198          DOI: 10.1186/s12885-020-07773-6

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  42 in total

1.  A Longitudinal Study of Depressive Symptoms in Patients With Head and Neck Cancer Undergoing Radiotherapy.

Authors:  Guro Lindviksmoen Astrup; Tone Rustøen; Christine Miaskowski; Steven M Paul; Kristin Bjordal
Journal:  Cancer Nurs       Date:  2015 Nov-Dec       Impact factor: 2.592

2.  European reference values for the quality of life questionnaire EORTC QLQ-C30: Results of a German investigation and a summarizing analysis of six European general population normative studies.

Authors:  Andreas Hinz; Susanne Singer; Elmar Brähler
Journal:  Acta Oncol       Date:  2014-01-23       Impact factor: 4.089

Review 3.  The development of an ICF-based clinical guideline and screening tool for the standardized assessment and evaluation of functioning after head and neck cancer treatment.

Authors:  Ulrich Kisser; Christine Adderson-Kisser; Michaela Coenen; Marita Stier-Jarmer; Sven Becker; Carla Sabariego; Ulrich Harréus
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-30       Impact factor: 2.503

4.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

5.  Four-week prevalence of mental disorders in patients with cancer across major tumor entities.

Authors:  Anja Mehnert; Elmar Brähler; Hermann Faller; Martin Härter; Monika Keller; Holger Schulz; Karl Wegscheider; Joachim Weis; Anna Boehncke; Bianca Hund; Katrin Reuter; Matthias Richard; Susanne Sehner; Sabine Sommerfeldt; Carina Szalai; Hans-Ulrich Wittchen; Uwe Koch
Journal:  J Clin Oncol       Date:  2014-10-06       Impact factor: 44.544

Review 6.  American Cancer Society Head and Neck Cancer Survivorship Care Guideline.

Authors:  Ezra E W Cohen; Samuel J LaMonte; Nicole L Erb; Kerry L Beckman; Nader Sadeghi; Katherine A Hutcheson; Michael D Stubblefield; Dennis M Abbott; Penelope S Fisher; Kevin D Stein; Gary H Lyman; Mandi L Pratt-Chapman
Journal:  CA Cancer J Clin       Date:  2016-03-22       Impact factor: 508.702

7.  Risk of depressive disorder among patients with head and neck cancer: A nationwide population-based study.

Authors:  Chao-Yueh Fan; Hsing-Lung Chao; Chun-Shu Lin; Wen-Yen Huang; Chang-Ming Chen; Kuen-Tze Lin; Cheng-Li Lin; Chia-Hung Kao
Journal:  Head Neck       Date:  2017-09-30       Impact factor: 3.147

8.  Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial.

Authors:  Kathryn E Lazure; William M Lydiatt; David Denman; William J Burke
Journal:  Head Neck       Date:  2009-07       Impact factor: 3.147

9.  Prevalence of Fatigue in Head and Neck Cancer Survivors.

Authors:  Paolo Bossi; Patricia Di Pede; Mauro Guglielmo; Roberta Granata; Salvatore Alfieri; Nicola Alessandro Iacovelli; Ester Orlandi; Marco Guzzo; Roberto Bianchi; Letizia Ferella; Gabriele Infante; Rosalba Miceli; Lisa Licitra; Carla Ida Ripamonti
Journal:  Ann Otol Rhinol Laryngol       Date:  2019-01-30       Impact factor: 1.547

10.  Assessment of depression severity with the PHQ-9 in cancer patients and in the general population.

Authors:  Andreas Hinz; Anja Mehnert; Rüya-Daniela Kocalevent; Elmar Brähler; Thomas Forkmann; Susanne Singer; Thomas Schulte
Journal:  BMC Psychiatry       Date:  2016-02-02       Impact factor: 3.630

View more
  6 in total

Review 1.  Barriers and facilitators to physical activity participation in patients with head and neck cancer: a scoping review.

Authors:  Yan Ning; Qian Wang; Yongxia Ding; Wenting Zhao; Zehuan Jia; Binquan Wang
Journal:  Support Care Cancer       Date:  2022-01-15       Impact factor: 3.603

2.  Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors.

Authors:  Puja Aggarwal; Katherine A Hutcheson; Ryan P Goepfert; Adam S Garden; Naveen Garg; Frank E Mott; Clifton D Fuller; Stephen Y Lai; Gary Brandon Gunn; Mark S Chambers; Ehab Y Hanna; Erich M Sturgis; Sanjay Shete
Journal:  Head Neck       Date:  2022-01-27       Impact factor: 3.147

3.  Screening for Distress and Health Outcomes in Head and Neck Cancer.

Authors:  Bryan Gascon; Aliza A Panjwani; Olivia Mazzurco; Madeline Li
Journal:  Curr Oncol       Date:  2022-05-24       Impact factor: 3.109

Review 4.  Health-Related Quality of Life, Psychosocial Distress and Unmet Needs in Older Patients With Head and Neck Cancer.

Authors:  Lachlan McDowell; Danny Rischin; Karla Gough; Christina Henson
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

5.  Web-Based Patient-Reported Outcomes for ENT Patients-Evaluation of the Status Quo, Patients' View, and Future Perspectives.

Authors:  Theresa Wald; Veit Zebralla; Maren Boege; Viktor Kunz; Thomas Neumuth; Andreas Dietz; Gunnar Wichmann; Susanne Wiegand
Journal:  Int J Environ Res Public Health       Date:  2022-09-18       Impact factor: 4.614

6.  Hope and Distress Are Not Associated With the Brain Tumor Stage.

Authors:  Simone Mayer; Stefanie Fuchs; Madeleine Fink; Norbert Schäffeler; Stephan Zipfel; Franziska Geiser; Heinz Reichmann; Björn Falkenburger; Marco Skardelly; Martin Teufel
Journal:  Front Psychol       Date:  2021-05-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.